2Nishibori T, Tannabe Y, Su L, et al. Impaired development of CD4+ CD25+ regulatory T cells in the absence of STATI: increased susceptibility to autoimmune diseases[J]. J Exp Med, 2004,199(1) :25-34.
3Raziuddin S, Sheikha AK. Phenotypie and functional T cell subset abnormalities in patients with aplastic anemia and hypogammaglobulinaemia[J]. Br J Haematol, 1988,70 ( 3 ): 283- 287.
4Lopez-Karpovitch X, Zarzosa MF, Cardenas MR, et al. Changes in peripheral blood mononuclear cell subpopulations during antithymocyte globulin therapy for severe aplastie anemia[J]. Aeta Haematol, 1989,81(4) : 176-180.
5Waldmann TA. Anti-Tac(daclizumab,Zenapax)in the treatment of leukemia, autoimmune diseases, and in the prevention of allograft rejection: a 25-year personal odyssey[J]. J Clin Immunol,2007,27(1) : 1-18.
6Schwinger W,Urban C, Lackner H, et al. Treatment of aplastic anemia with a monoclonal antibody directed against the interleukin-2 receptor[J].Annals Hematol, 1993,66 (4) : 181- 184.
8Dannufl J, Su Z, Rizzieri D, et al. Enhancement of vaccine- mediated antitumor immunity in cancer patients after depletion of regulatory T cells[J]. J Clin Invest, 2005, 115 (12) : 3623-3633.
2Piccirillo CA, Shevach EM. Naturally-occurring CD4 + CD25 +immunoregulatory T cells : central players in the arena of peripheral tolerance. Semin Immunol,2004,16(2) :81-88.
3Baecher-Allan C, Brown JA, Freeman GJ,et al. CD4+CD25high regulatory cells in human peripheral blood. J Immunol, 2001,167(3) :1245-1253.
4Campbell JJ. Tregs control B-cell life and death. Blood, 2006,107(10):3818-3819.
5Ghiringhelli F, Menard C, Terme M, et al. CD4 + CD25 +regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner. J Exp Med,2005,202 (8) : 1075-1085.
6Romagnani C, Della Chiesa M, Kohler S, et al. Activation of human NK cells by plasmacytoid dendritic cells and its modulation by CD4+ T helper cells and CD4+ CD25hi T regulatory cells. Eur J Immunol, 2005,35(8):2452-2458.
7Jiang S, Game DS, Davies D, et al. Activated CDld-restricted natural killer T cells secrete IL-2: innate help for CD4 +CD25 +regulatory T cells? Eur J Immunol, 2005,35(4):1193-1200.
8Azuma T, Takahashi T, Kunisato A, et al. Human CD4+ CD25+ regulatory T cells suppress NKT cell functions. Cancer Res,2003,63(15) :4516-4520.
9Liu R, La Cava A, Bai XF, et al. Cooperation of invariant NKT cells and CD4 + CD25 + T regulatory cells in the prevention of autoimmune myasthenia. J Immunol, 2005,175 (12) : 7898-7904.
10Crispin JC, Martinez A, Alcocer-Varela J. Quantification of regulatory T cells in patients with systemic lupus erythematosus. J Autoimmun, 2003,21 (3) : 273-276.
4Shin SH, Lee JW. The optimal immunosuppressive therapy for aplastic anemia[J]. Int J Hematol, 2013,97(6) :564-572.
5Jun Shi,Meili Ge, Yizhou Zheng, et al. Intrinsic impairment of CD4-CD26- regulatory T cells in acquired aplastic anemia [J]. Blood, 2012,120(8) : 1624-1632.
6de Latour RP, Visconte V, Takaku T, et al. Thl7 immune responses contribute to the pathophysiology of aplastic anemia [J]. Blood,2010,116(20) :4175-4184.
7Li JP, Zheng CL, Han ZC. Abnormal immunity and stem/ progenitor cells in acquired aplastic anemia[J]. Crit Rev Oncol Hematol, 2010,75 (2) : 79-93.
8Marsh JC, Ball SE, Cavenagh J, et al. Guidelines for the diagnosis and management of aplastic anaemia [J ]. Br J Haematol, 2009,147 (1) : 43-70.
9Rose S, Lichtenheld M, Foote M, et al. Murine neonatal CD4+ cells are poised for rapid Th2 effeetor-like function[J]. J Immunol,2007,178(5) :2667-2678.
10Sakaguchigh S, Sakaguchigh N, Asano M, et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor a-ehains(CD25). Breackdown of single mechanism of self-tolerance causes various autoimmune diseases [J]. J Immunol, 1995,155(3) :1151-1164.
